Biogen (BIIB) Intangibles (2009 - 2026)
Biogen's Intangibles came in at $13.52 billion for Q2 2026, up 42.8% from $9.47 billion a year earlier and up 49.3% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen's Intangibles was $9.18 billion, down 5.3% from FY2024.
- Intangibles carries a five-year compound annual growth rate of 24.4% (FY2020 to FY2025).
- Going back by year, Intangibles was $9.69 billion in FY2024 (+15.9%), $8.36 billion in FY2023 (+352.0%), $1.85 billion in FY2022 (-16.7%) and $2.22 billion in FY2021 (-28.0%).
- The Q2 2026 figure represents the highest quarterly Intangibles in data going back to Q2 2009.
- Year-over-year, Intangibles increased in five of the last eight quarters, with growth averaging 13.4%.
- The fastest year-over-year change in Intangibles over five years came in Q2 2024 (growth of 363.5%), and the weakest in Q3 2021 (a decline of 31.2%).
- Business Quant data shows BIIB's Intangibles at $9.05 billion (Q1 2026), $9.18 billion (Q4 2025) and $9.33 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn | 13.52 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.52 Bn |
| Mar 31, 2026 | 9.05 Bn |
| Dec 31, 2025 | 9.18 Bn |
| Sep 30, 2025 | 9.33 Bn |
| Jun 30, 2025 | 9.47 Bn |
| Mar 31, 2025 | 9.58 Bn |
| Dec 31, 2024 | 9.69 Bn |
| Sep 30, 2024 | 9.81 Bn |
| Jun 30, 2024 | 8.23 Bn |
| Mar 31, 2024 | 8.28 Bn |
| Dec 31, 2023 | 8.36 Bn |
| Sep 30, 2023 | 7.34 Bn |
| Jun 30, 2023 | 1.78 Bn |
| Mar 31, 2023 | 1.81 Bn |
| Dec 31, 2022 | 1.85 Bn |
| Sep 30, 2022 | 2.01 Bn |
| Jun 30, 2022 | 2.08 Bn |
| Mar 31, 2022 | 2.15 Bn |
| Dec 31, 2021 | 2.22 Bn |
| Sep 30, 2021 | 2.29 Bn |
API Access
Biogen Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();